Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Cel-Sci's HGP-30 AIDS vaccine shows recognition of major HIV subtypes

May 9, 1997

Viracept now available in Canada through expanded access program

May 9, 1997

Combination of MKC-442, zidovudine and lamivudine highly effective in vitro

May 7, 1997

BioCryst commences phase I trial of HIV compound

May 6, 1997

Hybridon and the Institute of Human Virology enter antisense AIDS therapy collaboration

May 6, 1997

Anti-HIV antisense oligonucleotides from Hybridon evaluated in SCID mice

May 5, 1997

Potent inhibitors of HIV-1 and other enveloped viruses reported

April 30, 1997

Vertex designs potent, conformationally restricted HIV protease inhibitors

April 30, 1997

Preclinical studies with GPI-2A reported by Genesys Pharma

April 30, 1997

ISIS-5320: preclinical study results

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...